Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
Authors
Keywords
-
Journal
PROSTATE
Volume 73, Issue 5, Pages 512-521
Publisher
Wiley
Online
2012-10-04
DOI
10.1002/pros.22591
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
- (2011) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer
- (2009) B Mellado et al. BRITISH JOURNAL OF CANCER
- Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
- (2009) L. Zhao et al. CANCER RESEARCH
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
- (2009) J. Y. Chun et al. CLINICAL CANCER RESEARCH
- Inflammation and cancer: how friendly is the relationship for cancer patients?
- (2009) Bharat B Aggarwal et al. CURRENT OPINION IN PHARMACOLOGY
- IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
- (2009) Julia Bollrath et al. EMBO REPORTS
- Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
- (2009) Frédéric R Santer et al. ENDOCRINE-RELATED CANCER
- New Insights Into the Role of Interleukin-6 in Human Prostate Cancer
- (2009) Zoran Culig JOURNAL OF UROLOGY
- Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2
- (2009) S. Feng et al. MOLECULAR CANCER THERAPEUTICS
- Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
- (2008) Kamilla Malinowska et al. ENDOCRINE-RELATED CANCER
- The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
- (2008) Marina Zemskova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel
- (2007) J. Domingo-Domenech et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now